Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.44957422 |
2 | negative regulation of cell killing (GO:0031342) | 5.44957422 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.00708651 |
4 | L-phenylalanine catabolic process (GO:0006559) | 5.00708651 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94833504 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.92648489 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.92648489 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.92648489 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.92648489 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.92648489 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.92648489 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.82597038 |
13 | L-phenylalanine metabolic process (GO:0006558) | 4.76517290 |
14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.76517290 |
15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.67619290 |
16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.42674476 |
17 | lysine metabolic process (GO:0006553) | 4.26088777 |
18 | lysine catabolic process (GO:0006554) | 4.26088777 |
19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25979253 |
20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15086862 |
21 | aromatic amino acid family catabolic process (GO:0009074) | 4.14321741 |
22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.13589434 |
23 | cysteine metabolic process (GO:0006534) | 4.10459452 |
24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.06667582 |
25 | sulfur amino acid catabolic process (GO:0000098) | 4.04363534 |
26 | macrophage activation involved in immune response (GO:0002281) | 3.98796955 |
27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.94979455 |
28 | response to peptidoglycan (GO:0032494) | 3.90017587 |
29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.89615119 |
30 | urea metabolic process (GO:0019627) | 3.88104259 |
31 | urea cycle (GO:0000050) | 3.88104259 |
32 | detection of other organism (GO:0098543) | 3.86014075 |
33 | negative regulation of fibrinolysis (GO:0051918) | 3.85383278 |
34 | kynurenine metabolic process (GO:0070189) | 3.84446744 |
35 | complement activation, alternative pathway (GO:0006957) | 3.82800278 |
36 | bile acid biosynthetic process (GO:0006699) | 3.81652243 |
37 | leukocyte aggregation (GO:0070486) | 3.77367530 |
38 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.71248643 |
39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71245979 |
40 | cellular extravasation (GO:0045123) | 3.69733345 |
41 | homocysteine metabolic process (GO:0050667) | 3.69120661 |
42 | regulation of protein activation cascade (GO:2000257) | 3.67333691 |
43 | regulation of cholesterol homeostasis (GO:2000188) | 3.66462024 |
44 | neutrophil activation involved in immune response (GO:0002283) | 3.65264412 |
45 | detection of bacterium (GO:0016045) | 3.62167584 |
46 | glyoxylate metabolic process (GO:0046487) | 3.60772716 |
47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.60752089 |
48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59547352 |
49 | cellular ketone body metabolic process (GO:0046950) | 3.59408646 |
50 | glutamate metabolic process (GO:0006536) | 3.55996727 |
51 | detection of molecule of bacterial origin (GO:0032490) | 3.52608434 |
52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.52095684 |
53 | regulation of complement activation (GO:0030449) | 3.49365153 |
54 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.49342164 |
55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.46931054 |
56 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.45385916 |
57 | protein carboxylation (GO:0018214) | 3.44531899 |
58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.44531899 |
59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.44508401 |
60 | aspartate family amino acid catabolic process (GO:0009068) | 3.43937804 |
61 | detection of external biotic stimulus (GO:0098581) | 3.42294102 |
62 | nitrogen cycle metabolic process (GO:0071941) | 3.42287691 |
63 | regulation of fibrinolysis (GO:0051917) | 3.41784184 |
64 | short-chain fatty acid metabolic process (GO:0046459) | 3.41093738 |
65 | indole-containing compound catabolic process (GO:0042436) | 3.37823364 |
66 | indolalkylamine catabolic process (GO:0046218) | 3.37823364 |
67 | tryptophan catabolic process (GO:0006569) | 3.37823364 |
68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36772514 |
69 | positive thymic T cell selection (GO:0045059) | 3.36242878 |
70 | regulation of triglyceride catabolic process (GO:0010896) | 3.34021726 |
71 | germinal center formation (GO:0002467) | 3.33411449 |
72 | acetyl-CoA metabolic process (GO:0006084) | 3.32987096 |
73 | cellular modified amino acid catabolic process (GO:0042219) | 3.32650125 |
74 | negative regulation of interleukin-12 production (GO:0032695) | 3.30909041 |
75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30356631 |
76 | negative regulation of cholesterol transport (GO:0032375) | 3.29363677 |
77 | negative regulation of sterol transport (GO:0032372) | 3.29363677 |
78 | amino-acid betaine metabolic process (GO:0006577) | 3.29020715 |
79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.27960255 |
80 | response to host immune response (GO:0052572) | 3.27960255 |
81 | bile acid metabolic process (GO:0008206) | 3.23269388 |
82 | serine family amino acid catabolic process (GO:0009071) | 3.21825330 |
83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21683131 |
84 | response to host (GO:0075136) | 3.21683131 |
85 | response to host defenses (GO:0052200) | 3.21683131 |
86 | tryptophan metabolic process (GO:0006568) | 3.21290932 |
87 | reverse cholesterol transport (GO:0043691) | 3.17252515 |
88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16044655 |
89 | acylglycerol homeostasis (GO:0055090) | 3.14379027 |
90 | triglyceride homeostasis (GO:0070328) | 3.14379027 |
91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14059729 |
92 | ketone body metabolic process (GO:1902224) | 3.12272402 |
93 | B cell receptor signaling pathway (GO:0050853) | 3.12191040 |
94 | tolerance induction (GO:0002507) | 3.09564804 |
95 | 2-oxoglutarate metabolic process (GO:0006103) | 3.09545986 |
96 | fatty acid transmembrane transport (GO:1902001) | 3.09052201 |
97 | alpha-amino acid catabolic process (GO:1901606) | 3.08875570 |
98 | positive regulation of lipid catabolic process (GO:0050996) | 3.07067548 |
99 | plasma lipoprotein particle clearance (GO:0034381) | 2.98465645 |
100 | cellular amino acid catabolic process (GO:0009063) | 2.97739603 |
101 | detection of biotic stimulus (GO:0009595) | 2.97677848 |
102 | carnitine shuttle (GO:0006853) | 2.97273814 |
103 | phospholipid homeostasis (GO:0055091) | 2.95936505 |
104 | positive T cell selection (GO:0043368) | 2.95504113 |
105 | regulation of T cell tolerance induction (GO:0002664) | 2.95002934 |
106 | neutrophil activation (GO:0042119) | 2.94988148 |
107 | T cell selection (GO:0045058) | 2.94754588 |
108 | ethanol oxidation (GO:0006069) | 2.94242568 |
109 | response to interleukin-15 (GO:0070672) | 2.94099376 |
110 | thymic T cell selection (GO:0045061) | 2.93876135 |
111 | tyrosine metabolic process (GO:0006570) | 2.93621984 |
112 | regulation of mast cell degranulation (GO:0043304) | 2.92718856 |
113 | macrophage activation (GO:0042116) | 2.91814321 |
114 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90215659 |
115 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89958635 |
116 | positive regulation of fatty acid oxidation (GO:0046321) | 2.87077565 |
117 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.86882686 |
118 | regulation of leukocyte degranulation (GO:0043300) | 2.86477415 |
119 | drug transmembrane transport (GO:0006855) | 2.84051978 |
120 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83594404 |
121 | aromatic amino acid family metabolic process (GO:0009072) | 2.83412817 |
122 | response to muramyl dipeptide (GO:0032495) | 2.83324365 |
123 | respiratory burst (GO:0045730) | 2.83174818 |
124 | 4-hydroxyproline metabolic process (GO:0019471) | 2.82906871 |
125 | coenzyme catabolic process (GO:0009109) | 2.82575748 |
126 | protein-lipid complex remodeling (GO:0034368) | 2.82380095 |
127 | macromolecular complex remodeling (GO:0034367) | 2.82380095 |
128 | plasma lipoprotein particle remodeling (GO:0034369) | 2.82380095 |
129 | drug catabolic process (GO:0042737) | 2.82159164 |
130 | fatty acid beta-oxidation (GO:0006635) | 2.82087602 |
131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.81107584 |
132 | cytolysis (GO:0019835) | 2.80563273 |
133 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.80071391 |
134 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.78442076 |
135 | regulation of necroptotic process (GO:0060544) | 2.78336353 |
136 | phospholipid efflux (GO:0033700) | 2.78330477 |
137 | granulocyte activation (GO:0036230) | 2.78238178 |
138 | mannose metabolic process (GO:0006013) | 2.78065464 |
139 | negative regulation of interleukin-6 production (GO:0032715) | 2.77965717 |
140 | cholesterol efflux (GO:0033344) | 2.77022221 |
141 | regulation of tolerance induction (GO:0002643) | 2.77017950 |
142 | negative thymic T cell selection (GO:0045060) | 2.76228886 |
143 | plasma lipoprotein particle assembly (GO:0034377) | 2.76096893 |
144 | epoxygenase P450 pathway (GO:0019373) | 2.76055827 |
145 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.75688719 |
146 | dicarboxylic acid catabolic process (GO:0043649) | 2.75620881 |
147 | microglial cell activation (GO:0001774) | 2.75312907 |
148 | fatty acid oxidation (GO:0019395) | 2.74702868 |
149 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73710157 |
150 | response to laminar fluid shear stress (GO:0034616) | 2.72221009 |
151 | protein-lipid complex assembly (GO:0065005) | 2.71852519 |
152 | histone H3-K36 demethylation (GO:0070544) | 2.71824205 |
153 | regulation of fatty acid oxidation (GO:0046320) | 2.71208582 |
154 | negative T cell selection (GO:0043383) | 2.70747907 |
155 | amino-acid betaine transport (GO:0015838) | 2.69715710 |
156 | carnitine transport (GO:0015879) | 2.69715710 |
157 | immunoglobulin mediated immune response (GO:0016064) | 2.69042405 |
158 | protein localization to endosome (GO:0036010) | 2.68388386 |
159 | lipid oxidation (GO:0034440) | 2.67490266 |
160 | myeloid cell activation involved in immune response (GO:0002275) | 2.67120630 |
161 | fatty acid catabolic process (GO:0009062) | 2.66384921 |
162 | macroautophagy (GO:0016236) | 2.66366594 |
163 | carnitine transmembrane transport (GO:1902603) | 2.66116057 |
164 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.64794493 |
165 | monocarboxylic acid catabolic process (GO:0072329) | 2.63895472 |
166 | negative regulation of cell size (GO:0045792) | 2.62258304 |
167 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.61634000 |
168 | hormone catabolic process (GO:0042447) | 2.60684105 |
169 | negative regulation of protein activation cascade (GO:2000258) | 2.60594489 |
170 | neutrophil mediated immunity (GO:0002446) | 2.60265588 |
171 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.59844356 |
172 | defense response to protozoan (GO:0042832) | 2.59248720 |
173 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.58130257 |
174 | carboxylic acid catabolic process (GO:0046395) | 2.57658101 |
175 | organic acid catabolic process (GO:0016054) | 2.57658101 |
176 | valine metabolic process (GO:0006573) | 2.57100705 |
177 | sterol homeostasis (GO:0055092) | 2.56090883 |
178 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.55958486 |
179 | cellular response to interleukin-15 (GO:0071350) | 2.55005346 |
180 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.53726543 |
181 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.53135238 |
182 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.51277898 |
183 | response to type I interferon (GO:0034340) | 2.50274214 |
184 | negative regulation of type 2 immune response (GO:0002829) | 2.49412070 |
185 | positive regulation of Rap GTPase activity (GO:0032854) | 2.48602221 |
186 | cellular response to type I interferon (GO:0071357) | 2.48214092 |
187 | type I interferon signaling pathway (GO:0060337) | 2.48214092 |
188 | activated T cell proliferation (GO:0050798) | 2.47453999 |
189 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.46769588 |
190 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.46769588 |
191 | regulation of regulated secretory pathway (GO:1903305) | 2.46735605 |
192 | T cell migration (GO:0072678) | 2.45770690 |
193 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.45666869 |
194 | negative regulation of innate immune response (GO:0045824) | 2.44861417 |
195 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.44110457 |
196 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.40679583 |
197 | positive regulation of mast cell activation (GO:0033005) | 2.40348576 |
198 | regulation of mast cell activation (GO:0033003) | 2.39839548 |
199 | regulation of ARF protein signal transduction (GO:0032012) | 2.39141480 |
200 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.37982288 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.07452419 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.63054208 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.10158418 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.99181737 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.36509141 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.29689255 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18069516 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.11698083 |
9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.00962501 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.94881803 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.91361115 |
12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86365847 |
13 | MYC_22102868_ChIP-Seq_BL_Human | 2.68061614 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50332085 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50211746 |
16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34991599 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22842947 |
18 | MAF_26560356_Chip-Seq_TH1_Human | 2.22519738 |
19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.21654420 |
20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20048829 |
21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.12996595 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.12274832 |
23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08898217 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08818770 |
25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.06456489 |
26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01543248 |
27 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01524289 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98032322 |
29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95894102 |
30 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.95854431 |
31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94992514 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92152865 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90802437 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90638055 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88829651 |
36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85066364 |
37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83732503 |
38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82547468 |
39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78800931 |
40 | MAF_26560356_Chip-Seq_TH2_Human | 1.77758023 |
41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.75996729 |
42 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71971613 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69800807 |
44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64464517 |
45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64254974 |
46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61179014 |
47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60967893 |
48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55093791 |
49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54322638 |
50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53877236 |
51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48156668 |
52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46781836 |
53 | MYB_26560356_Chip-Seq_TH2_Human | 1.45926785 |
54 | MYB_26560356_Chip-Seq_TH1_Human | 1.45158435 |
55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44552401 |
56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44455224 |
57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42813345 |
58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42793892 |
59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41581816 |
60 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.38878192 |
61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38202770 |
62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38076106 |
63 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.37048005 |
64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36988997 |
65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36843723 |
66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35562357 |
67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34118330 |
68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32486128 |
69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31909688 |
70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30115301 |
71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29846778 |
72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29723944 |
73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29591686 |
74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28798889 |
75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25849048 |
76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25650461 |
77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25014967 |
78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24390152 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23408885 |
80 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.22935771 |
81 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22063551 |
82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20245471 |
83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18324511 |
84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.16964122 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15240751 |
86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14958062 |
87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13962195 |
88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13120521 |
89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13108978 |
90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12809778 |
91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12349913 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11674758 |
93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11156547 |
94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11156547 |
95 | P68_20966046_ChIP-Seq_HELA_Human | 1.10497017 |
96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09457487 |
97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09046196 |
98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08897939 |
99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08759051 |
100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08728439 |
101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08667699 |
102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07717912 |
103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07606503 |
104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07439161 |
105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07138499 |
106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06301510 |
107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05156754 |
108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02226578 |
109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01781836 |
110 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01723555 |
111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01415594 |
112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01369378 |
113 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01038450 |
114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99043439 |
115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99009523 |
116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98439477 |
117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98386105 |
118 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97376800 |
119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97153303 |
120 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97019472 |
121 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.97015117 |
122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96954567 |
123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96302517 |
124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95704114 |
125 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95546028 |
126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94906372 |
127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94685639 |
128 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93750190 |
129 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.93279929 |
130 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92143056 |
131 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90769933 |
132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90673422 |
133 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90476305 |
134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88574131 |
135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87976851 |
136 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87706018 |
137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87619378 |
138 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.85381796 |
139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84248033 |
140 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84232064 |
141 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83308056 |
142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82115561 |
143 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81907121 |
144 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81347812 |
145 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80528425 |
146 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80360562 |
147 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80047408 |
148 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79030846 |
149 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.77854917 |
150 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.77768117 |
151 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77280440 |
152 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76316626 |
153 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75308533 |
154 | AR_19668381_ChIP-Seq_PC3_Human | 0.74812415 |
155 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74541932 |
156 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73804062 |
157 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.73800654 |
158 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.73416187 |
159 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72719268 |
160 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.72406498 |
161 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71652073 |
162 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.71481478 |
163 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.71459086 |
164 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.70585194 |
165 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.70585194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.37667983 |
2 | MP0005360_urolithiasis | 5.51081038 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.70063463 |
4 | MP0005365_abnormal_bile_salt | 4.53332095 |
5 | MP0003436_decreased_susceptibility_to | 3.69509290 |
6 | MP0003705_abnormal_hypodermis_morpholog | 3.33276987 |
7 | MP0003252_abnormal_bile_duct | 3.33271835 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.32418149 |
9 | MP0003724_increased_susceptibility_to | 3.27839526 |
10 | MP0010329_abnormal_lipoprotein_level | 2.93294027 |
11 | MP0005451_abnormal_body_composition | 2.92544815 |
12 | MP0001835_abnormal_antigen_presentation | 2.53077300 |
13 | MP0000685_abnormal_immune_system | 2.44010136 |
14 | MP0002419_abnormal_innate_immunity | 2.40961040 |
15 | MP0001800_abnormal_humoral_immune | 2.37142021 |
16 | MP0003195_calcinosis | 2.36967249 |
17 | MP0005083_abnormal_biliary_tract | 2.33561320 |
18 | MP0002837_dystrophic_cardiac_calcinosis | 2.33107961 |
19 | MP0001790_abnormal_immune_system | 2.32259035 |
20 | MP0005387_immune_system_phenotype | 2.32259035 |
21 | MP0003763_abnormal_thymus_physiology | 2.27030014 |
22 | MP0005025_abnormal_response_to | 2.23367532 |
23 | MP0005000_abnormal_immune_tolerance | 2.22747902 |
24 | MP0003183_abnormal_peptide_metabolism | 2.18364794 |
25 | MP0001666_abnormal_nutrient_absorption | 2.15437189 |
26 | MP0005332_abnormal_amino_acid | 2.11989310 |
27 | MP0010234_abnormal_vibrissa_follicle | 2.11826937 |
28 | MP0003806_abnormal_nucleotide_metabolis | 2.08221692 |
29 | MP0003828_pulmonary_edema | 2.04169260 |
30 | MP0002723_abnormal_immune_serum | 2.00499683 |
31 | MP0002452_abnormal_antigen_presenting | 2.00157233 |
32 | MP0002420_abnormal_adaptive_immunity | 1.99747559 |
33 | MP0001819_abnormal_immune_cell | 1.97086539 |
34 | MP0004130_abnormal_muscle_cell | 1.96600997 |
35 | MP0009785_altered_susceptibility_to | 1.96441900 |
36 | MP0003329_amyloid_beta_deposits | 1.95912354 |
37 | MP0002118_abnormal_lipid_homeostasis | 1.95221337 |
38 | MP0005671_abnormal_response_to | 1.94155783 |
39 | MP0008260_abnormal_autophagy | 1.93848352 |
40 | MP0004510_myositis | 1.91922449 |
41 | MP0004947_skin_inflammation | 1.89121033 |
42 | MP0009840_abnormal_foam_cell | 1.88357639 |
43 | MP0000609_abnormal_liver_physiology | 1.84350705 |
44 | MP0001533_abnormal_skeleton_physiology | 1.80306368 |
45 | MP0005670_abnormal_white_adipose | 1.78482953 |
46 | MP0003191_abnormal_cellular_cholesterol | 1.75540099 |
47 | MP0009780_abnormal_chondrocyte_physiolo | 1.74857379 |
48 | MP0009333_abnormal_splenocyte_physiolog | 1.74213109 |
49 | MP0003646_muscle_fatigue | 1.71245203 |
50 | MP0008961_abnormal_basal_metabolism | 1.68316002 |
51 | MP0004859_abnormal_synaptic_plasticity | 1.67139815 |
52 | MP0003300_gastrointestinal_ulcer | 1.66669480 |
53 | MP0002909_abnormal_adrenal_gland | 1.64494003 |
54 | MP0000604_amyloidosis | 1.60123377 |
55 | MP0004381_abnormal_hair_follicle | 1.59075725 |
56 | MP0002148_abnormal_hypersensitivity_rea | 1.57670047 |
57 | MP0002405_respiratory_system_inflammati | 1.55292369 |
58 | MP0003172_abnormal_lysosome_physiology | 1.52568125 |
59 | MP0002398_abnormal_bone_marrow | 1.52451592 |
60 | MP0000716_abnormal_immune_system | 1.52319690 |
61 | MP0006082_CNS_inflammation | 1.50908190 |
62 | MP0000749_muscle_degeneration | 1.50050299 |
63 | MP0005464_abnormal_platelet_physiology | 1.49219403 |
64 | MP0005410_abnormal_fertilization | 1.47901337 |
65 | MP0005666_abnormal_adipose_tissue | 1.46876639 |
66 | MP0010155_abnormal_intestine_physiology | 1.46430939 |
67 | MP0004185_abnormal_adipocyte_glucose | 1.43822366 |
68 | MP0002138_abnormal_hepatobiliary_system | 1.39122741 |
69 | MP0001845_abnormal_inflammatory_respons | 1.35983976 |
70 | MP0002822_catalepsy | 1.34228514 |
71 | MP0002998_abnormal_bone_remodeling | 1.33813468 |
72 | MP0002332_abnormal_exercise_endurance | 1.33200327 |
73 | MP0001873_stomach_inflammation | 1.31144086 |
74 | MP0003868_abnormal_feces_composition | 1.30300266 |
75 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29053648 |
76 | MP0002132_abnormal_respiratory_system | 1.28186613 |
77 | MP0003091_abnormal_cell_migration | 1.27861761 |
78 | MP0005319_abnormal_enzyme/_coenzyme | 1.27660495 |
79 | MP0000703_abnormal_thymus_morphology | 1.25587569 |
80 | MP0002722_abnormal_immune_system | 1.25111678 |
81 | MP0009384_cardiac_valve_regurgitation | 1.21876040 |
82 | MP0000013_abnormal_adipose_tissue | 1.21393383 |
83 | MP0002971_abnormal_brown_adipose | 1.20922317 |
84 | MP0000759_abnormal_skeletal_muscle | 1.20705345 |
85 | MP0005310_abnormal_salivary_gland | 1.19922228 |
86 | MP0005375_adipose_tissue_phenotype | 1.19150235 |
87 | MP0000689_abnormal_spleen_morphology | 1.18572321 |
88 | MP0008469_abnormal_protein_level | 1.17370032 |
89 | MP0003866_abnormal_defecation | 1.17098713 |
90 | MP0009278_abnormal_bone_marrow | 1.16524475 |
91 | MP0000750_abnormal_muscle_regeneration | 1.16299402 |
92 | MP0002429_abnormal_blood_cell | 1.15768522 |
93 | MP0003283_abnormal_digestive_organ | 1.13559827 |
94 | MP0000858_altered_metastatic_potential | 1.13115977 |
95 | MP0004043_abnormal_pH_regulation | 1.11880633 |
96 | MP0002078_abnormal_glucose_homeostasis | 1.11534086 |
97 | MP0005409_darkened_coat_color | 1.11457142 |
98 | MP0000003_abnormal_adipose_tissue | 1.10655066 |
99 | MP0009643_abnormal_urine_homeostasis | 1.10199726 |
100 | MP0004019_abnormal_vitamin_homeostasis | 1.10095164 |
101 | MP0005166_decreased_susceptibility_to | 1.09162298 |
102 | MP0002877_abnormal_melanocyte_morpholog | 1.08954343 |
103 | MP0001851_eye_inflammation | 1.06041604 |
104 | MP0003453_abnormal_keratinocyte_physiol | 1.04995281 |
105 | MP0004883_abnormal_blood_vessel | 0.98409817 |
106 | MP0002277_abnormal_respiratory_mucosa | 0.97811523 |
107 | MP0005535_abnormal_body_temperature | 0.96391067 |
108 | MP0000747_muscle_weakness | 0.94898380 |
109 | MP0002166_altered_tumor_susceptibility | 0.94307619 |
110 | MP0005334_abnormal_fat_pad | 0.92678093 |
111 | MP0003690_abnormal_glial_cell | 0.92486015 |
112 | MP0002106_abnormal_muscle_physiology | 0.91375779 |
113 | MP0004145_abnormal_muscle_electrophysio | 0.91004583 |
114 | MP0002269_muscular_atrophy | 0.90858350 |
115 | MP0002928_abnormal_bile_duct | 0.90339886 |
116 | MP0005167_abnormal_blood-brain_barrier | 0.88861266 |
117 | MP0002396_abnormal_hematopoietic_system | 0.87979502 |
118 | MP0005076_abnormal_cell_differentiation | 0.87020780 |
119 | MP0003656_abnormal_erythrocyte_physiolo | 0.84245694 |
120 | MP0000733_abnormal_muscle_development | 0.83774556 |
121 | MP0000465_gastrointestinal_hemorrhage | 0.83590804 |
122 | MP0003635_abnormal_synaptic_transmissio | 0.83578713 |
123 | MP0005623_abnormal_meninges_morphology | 0.82273685 |
124 | MP0005448_abnormal_energy_balance | 0.82179871 |
125 | MP0003633_abnormal_nervous_system | 0.81866660 |
126 | MP0002009_preneoplasia | 0.81715641 |
127 | MP0004087_abnormal_muscle_fiber | 0.81153128 |
128 | MP0004233_abnormal_muscle_weight | 0.81067640 |
129 | MP0001958_emphysema | 0.80583062 |
130 | MP0008438_abnormal_cutaneous_collagen | 0.80573522 |
131 | MP0000598_abnormal_liver_morphology | 0.80472154 |
132 | MP0003279_aneurysm | 0.78367744 |
133 | MP0003303_peritoneal_inflammation | 0.78365929 |
134 | MP0009764_decreased_sensitivity_to | 0.78276804 |
135 | MP0003448_altered_tumor_morphology | 0.77331692 |
136 | MP0002896_abnormal_bone_mineralization | 0.76823167 |
137 | MP0004858_abnormal_nervous_system | 0.76453022 |
138 | MP0004270_analgesia | 0.75994811 |
139 | MP0001765_abnormal_ion_homeostasis | 0.74553480 |
140 | MP0005390_skeleton_phenotype | 0.74476824 |
141 | MP0000751_myopathy | 0.74361472 |
142 | MP0005187_abnormal_penis_morphology | 0.74318439 |
143 | MP0004484_altered_response_of | 0.74059324 |
144 | MP0002063_abnormal_learning/memory/cond | 0.74006877 |
145 | MP0002933_joint_inflammation | 0.73936765 |
146 | MP0005220_abnormal_exocrine_pancreas | 0.72901164 |
147 | MP0003045_fibrosis | 0.72630865 |
148 | MP0002254_reproductive_system_inflammat | 0.70596692 |
149 | MP0001756_abnormal_urination | 0.69904328 |
150 | MP0001944_abnormal_pancreas_morphology | 0.69430929 |
151 | MP0002234_abnormal_pharynx_morphology | 0.69295834 |
152 | MP0008874_decreased_physiological_sensi | 0.68467352 |
153 | MP0001661_extended_life_span | 0.68095681 |
154 | MP0010368_abnormal_lymphatic_system | 0.66626174 |
155 | MP0005330_cardiomyopathy | 0.66139113 |
156 | MP0003075_altered_response_to | 0.66101654 |
157 | MP0004885_abnormal_endolymph | 0.63033590 |
158 | MP0002970_abnormal_white_adipose | 0.62242846 |
159 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62003205 |
160 | MP0005636_abnormal_mineral_homeostasis | 0.60996873 |
161 | MP0003953_abnormal_hormone_level | 0.60779492 |
162 | MP0002168_other_aberrant_phenotype | 0.60749298 |
163 | MP0009672_abnormal_birth_weight | 0.60528189 |
164 | MP0009642_abnormal_blood_homeostasis | 0.60296108 |
165 | MP0003631_nervous_system_phenotype | 0.54142541 |
166 | MP0004036_abnormal_muscle_relaxation | 0.53406155 |
167 | MP0005647_abnormal_sex_gland | 0.52984936 |
168 | MP0010630_abnormal_cardiac_muscle | 0.52361652 |
169 | MP0005058_abnormal_lysosome_morphology | 0.51641016 |
170 | MP0004264_abnormal_extraembryonic_tissu | 0.50857135 |
171 | MP0001984_abnormal_olfaction | 0.48686650 |
172 | MP0003959_abnormal_lean_body | 0.48461313 |
173 | MP0003566_abnormal_cell_adhesion | 0.44895890 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.42940884 |
2 | Eczematoid dermatitis (HP:0000976) | 5.29253202 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.30391646 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.24533810 |
5 | Xanthomatosis (HP:0000991) | 4.21885995 |
6 | Abnormality of macrophages (HP:0004311) | 4.04276658 |
7 | Complement deficiency (HP:0004431) | 4.03821066 |
8 | Muscle fiber inclusion bodies (HP:0100299) | 3.97715510 |
9 | Recurrent abscess formation (HP:0002722) | 3.96881370 |
10 | Recurrent bacterial skin infections (HP:0005406) | 3.92201264 |
11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.83112727 |
12 | Nemaline bodies (HP:0003798) | 3.83055523 |
13 | Myositis (HP:0100614) | 3.79030017 |
14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.68589061 |
15 | Orchitis (HP:0100796) | 3.65677749 |
16 | Ketosis (HP:0001946) | 3.63655036 |
17 | Hypobetalipoproteinemia (HP:0003563) | 3.50146231 |
18 | Hyperlipoproteinemia (HP:0010980) | 3.48783493 |
19 | Hypoglycemic coma (HP:0001325) | 3.44975742 |
20 | Retrobulbar optic neuritis (HP:0100654) | 3.44198514 |
21 | Optic neuritis (HP:0100653) | 3.44198514 |
22 | Gastrointestinal infarctions (HP:0005244) | 3.43202409 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43148423 |
24 | Ketoacidosis (HP:0001993) | 3.27296196 |
25 | Type 1 muscle fiber predominance (HP:0003803) | 3.20894023 |
26 | Hypoalphalipoproteinemia (HP:0003233) | 3.11534816 |
27 | Hyperammonemia (HP:0001987) | 3.09965938 |
28 | Epidermoid cyst (HP:0200040) | 3.06311491 |
29 | Hypolipoproteinemia (HP:0010981) | 3.04724812 |
30 | Abnormality of the common coagulation pathway (HP:0010990) | 2.99534485 |
31 | Stomatitis (HP:0010280) | 2.98029525 |
32 | Muscle fiber splitting (HP:0003555) | 2.93013653 |
33 | Abnormality of complement system (HP:0005339) | 2.91714329 |
34 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.91398212 |
35 | Spontaneous hematomas (HP:0007420) | 2.88894985 |
36 | Mediastinal lymphadenopathy (HP:0100721) | 2.85915852 |
37 | Increased connective tissue (HP:0009025) | 2.82666192 |
38 | Recurrent fungal infections (HP:0002841) | 2.82162012 |
39 | Hyperglycinemia (HP:0002154) | 2.81655359 |
40 | Asymmetric septal hypertrophy (HP:0001670) | 2.80874962 |
41 | Cerebral inclusion bodies (HP:0100314) | 2.78671744 |
42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.78568009 |
43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.75883111 |
44 | Prolonged partial thromboplastin time (HP:0003645) | 2.75152786 |
45 | Hyperglycinuria (HP:0003108) | 2.74807617 |
46 | Myopathic facies (HP:0002058) | 2.74723136 |
47 | Meningitis (HP:0001287) | 2.71190058 |
48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69298336 |
49 | Obstructive lung disease (HP:0006536) | 2.69298336 |
50 | Skin nodule (HP:0200036) | 2.67401772 |
51 | Abnormality of the lower motor neuron (HP:0002366) | 2.67377833 |
52 | Gingivitis (HP:0000230) | 2.67292009 |
53 | Abnormality of glycine metabolism (HP:0010895) | 2.66281100 |
54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.66281100 |
55 | Gout (HP:0001997) | 2.65751031 |
56 | Ulnar deviation of the wrist (HP:0003049) | 2.64684944 |
57 | EMG: myopathic abnormalities (HP:0003458) | 2.63400588 |
58 | Myocardial infarction (HP:0001658) | 2.62535171 |
59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.62130039 |
60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59151679 |
61 | Distal lower limb muscle weakness (HP:0009053) | 2.58331333 |
62 | Increased IgE level (HP:0003212) | 2.55321032 |
63 | Increased variability in muscle fiber diameter (HP:0003557) | 2.55145818 |
64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54107451 |
65 | Back pain (HP:0003418) | 2.53927314 |
66 | Obstructive sleep apnea (HP:0002870) | 2.53099100 |
67 | Abnormality of the Achilles tendon (HP:0005109) | 2.51600902 |
68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.50659094 |
69 | Cellulitis (HP:0100658) | 2.49581586 |
70 | Recurrent skin infections (HP:0001581) | 2.47730165 |
71 | Sensorimotor neuropathy (HP:0007141) | 2.43608767 |
72 | Abnormality of the intrinsic pathway (HP:0010989) | 2.43566693 |
73 | Slow saccadic eye movements (HP:0000514) | 2.42556381 |
74 | Vasculitis (HP:0002633) | 2.42127367 |
75 | Chest pain (HP:0100749) | 2.40580508 |
76 | Keratoconjunctivitis sicca (HP:0001097) | 2.40484426 |
77 | Hypercholesterolemia (HP:0003124) | 2.39659166 |
78 | Neurofibrillary tangles (HP:0002185) | 2.39373068 |
79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36532928 |
80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.32290438 |
81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.32290438 |
82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.32290438 |
83 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.30628319 |
84 | Lymphangioma (HP:0100764) | 2.29406674 |
85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.27595473 |
86 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.27595473 |
87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.26112070 |
88 | Hypoglycemic seizures (HP:0002173) | 2.25538964 |
89 | Polycythemia (HP:0001901) | 2.24291235 |
90 | Encephalitis (HP:0002383) | 2.23493225 |
91 | Fat malabsorption (HP:0002630) | 2.22150417 |
92 | Abnormality of the fingertips (HP:0001211) | 2.18440382 |
93 | Abnormal gallbladder physiology (HP:0012438) | 2.16696449 |
94 | Cholecystitis (HP:0001082) | 2.16696449 |
95 | Hypochromic anemia (HP:0001931) | 2.15787755 |
96 | Urticaria (HP:0001025) | 2.15769140 |
97 | Gastrointestinal inflammation (HP:0004386) | 2.15507584 |
98 | Inflammation of the large intestine (HP:0002037) | 2.15472119 |
99 | Colitis (HP:0002583) | 2.15230591 |
100 | Macroorchidism (HP:0000053) | 2.14170688 |
101 | Arterial thrombosis (HP:0004420) | 2.13878218 |
102 | Global brain atrophy (HP:0002283) | 2.13598990 |
103 | Hepatocellular carcinoma (HP:0001402) | 2.10720972 |
104 | Hemoptysis (HP:0002105) | 2.10120163 |
105 | Pustule (HP:0200039) | 2.10089706 |
106 | Myoglobinuria (HP:0002913) | 2.09194241 |
107 | Abnormality of purine metabolism (HP:0004352) | 2.08330672 |
108 | Achilles tendon contracture (HP:0001771) | 2.07865185 |
109 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.07687563 |
110 | Subaortic stenosis (HP:0001682) | 2.07687563 |
111 | Keratoconjunctivitis (HP:0001096) | 2.07085235 |
112 | Amyloidosis (HP:0011034) | 2.07008272 |
113 | Prolonged bleeding time (HP:0003010) | 2.04251844 |
114 | Bulbar palsy (HP:0001283) | 2.04204315 |
115 | Mitral stenosis (HP:0001718) | 2.03958212 |
116 | Status epilepticus (HP:0002133) | 2.03009512 |
117 | Abnormality of the endocardium (HP:0004306) | 2.02950081 |
118 | Thin bony cortex (HP:0002753) | 2.01565103 |
119 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.01366836 |
120 | Turricephaly (HP:0000262) | 2.00276603 |
121 | Peritonitis (HP:0002586) | 2.00126138 |
122 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.99936016 |
123 | Dysostosis multiplex (HP:0000943) | 1.99844028 |
124 | Hyperglycemia (HP:0003074) | 1.98879866 |
125 | Pulmonary infiltrates (HP:0002113) | 1.98031910 |
126 | Cholelithiasis (HP:0001081) | 1.97698962 |
127 | Abnormal cartilage morphology (HP:0002763) | 1.96065950 |
128 | Frequent falls (HP:0002359) | 1.95841226 |
129 | Easy fatigability (HP:0003388) | 1.95117828 |
130 | Abnormal gallbladder morphology (HP:0012437) | 1.94605288 |
131 | Hyporeflexia of lower limbs (HP:0002600) | 1.94374183 |
132 | Gingival bleeding (HP:0000225) | 1.94246278 |
133 | T lymphocytopenia (HP:0005403) | 1.92645832 |
134 | Distal lower limb amyotrophy (HP:0008944) | 1.92513924 |
135 | Recurrent viral infections (HP:0004429) | 1.92325991 |
136 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.91628499 |
137 | Cerebral aneurysm (HP:0004944) | 1.90645157 |
138 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90192468 |
139 | Difficulty running (HP:0009046) | 1.88442442 |
140 | Distal arthrogryposis (HP:0005684) | 1.88211767 |
141 | Neonatal onset (HP:0003623) | 1.87642097 |
142 | Resting tremor (HP:0002322) | 1.86272189 |
143 | Osteomyelitis (HP:0002754) | 1.86258689 |
144 | Round ear (HP:0100830) | 1.86235040 |
145 | Increased CSF protein (HP:0002922) | 1.85744315 |
146 | Epistaxis (HP:0000421) | 1.84348392 |
147 | Acne (HP:0001061) | 1.84080707 |
148 | Hyperbilirubinemia (HP:0002904) | 1.83714817 |
149 | Exercise-induced myalgia (HP:0003738) | 1.83713260 |
150 | Dysmetric saccades (HP:0000641) | 1.83609591 |
151 | Pulmonary embolism (HP:0002204) | 1.83380999 |
152 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83312502 |
153 | Mucopolysacchariduria (HP:0008155) | 1.83312502 |
154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83292840 |
155 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83292840 |
156 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83292840 |
157 | Increased serum ferritin (HP:0003281) | 1.81889893 |
158 | Intention tremor (HP:0002080) | 1.80896316 |
159 | Fatigue (HP:0012378) | 1.80756396 |
160 | Retinal atrophy (HP:0001105) | 1.80611696 |
161 | Gastrointestinal stroma tumor (HP:0100723) | 1.80203695 |
162 | Calf muscle hypertrophy (HP:0008981) | 1.79386687 |
163 | Rhabdomyolysis (HP:0003201) | 1.78370525 |
164 | Abnormality of T cell number (HP:0011839) | 1.78361981 |
165 | Malnutrition (HP:0004395) | 1.78305961 |
166 | Restrictive lung disease (HP:0002091) | 1.77151129 |
167 | Aneurysm (HP:0002617) | 1.76835713 |
168 | Insidious onset (HP:0003587) | 1.75753049 |
169 | Termporal pattern (HP:0011008) | 1.75753049 |
170 | Abnormal social behavior (HP:0012433) | 1.74523140 |
171 | Impaired social interactions (HP:0000735) | 1.74523140 |
172 | Abnormality of methionine metabolism (HP:0010901) | 1.74136201 |
173 | Death in childhood (HP:0003819) | 1.74074972 |
174 | Mitral valve prolapse (HP:0001634) | 1.72816724 |
175 | Hypochromic microcytic anemia (HP:0004840) | 1.72600240 |
176 | Acanthocytosis (HP:0001927) | 1.72237738 |
177 | Visceral angiomatosis (HP:0100761) | 1.71854292 |
178 | Late onset (HP:0003584) | 1.71163696 |
179 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.69166129 |
180 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.69166129 |
181 | Abnormality of nucleobase metabolism (HP:0010932) | 1.67758530 |
182 | Hamartoma of the eye (HP:0010568) | 1.67723035 |
183 | Joint hemorrhage (HP:0005261) | 1.67599928 |
184 | Reticulocytosis (HP:0001923) | 1.65496466 |
185 | Insomnia (HP:0100785) | 1.65301701 |
186 | Long toe (HP:0010511) | 1.63947748 |
187 | Exercise-induced muscle cramps (HP:0003710) | 1.62771545 |
188 | Hemangiomatosis (HP:0007461) | 1.61094137 |
189 | Abnormality of the gallbladder (HP:0005264) | 1.60823945 |
190 | Hemorrhage of the eye (HP:0011885) | 1.60053890 |
191 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.59715526 |
192 | Spastic diplegia (HP:0001264) | 1.59382107 |
193 | Delayed CNS myelination (HP:0002188) | 1.58724467 |
194 | Stroke (HP:0001297) | 1.58685038 |
195 | Increased purine levels (HP:0004368) | 1.58430448 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.91021469 |
2 | PRPF4B | 3.40898402 |
3 | RIPK4 | 3.11743067 |
4 | MAP3K10 | 3.03542990 |
5 | PKN2 | 2.73680763 |
6 | PRKD3 | 2.63763572 |
7 | MAP4K1 | 2.60719724 |
8 | MAP2K3 | 2.60640339 |
9 | ERN1 | 2.53711833 |
10 | IRAK4 | 2.51054347 |
11 | ICK | 2.19711184 |
12 | SIK1 | 2.17894852 |
13 | BLK | 2.16466292 |
14 | TYK2 | 2.08813565 |
15 | BCKDK | 2.06122109 |
16 | RIPK1 | 2.02050234 |
17 | MAP3K9 | 2.01321882 |
18 | PDK4 | 1.94362297 |
19 | PDK3 | 1.94362297 |
20 | LATS1 | 1.93117611 |
21 | CSK | 1.93086280 |
22 | OBSCN | 1.89317482 |
23 | MAP3K13 | 1.82003287 |
24 | CAMK1G | 1.75668112 |
25 | KSR2 | 1.74489410 |
26 | MAP3K3 | 1.65625723 |
27 | ZAP70 | 1.61332380 |
28 | MAP3K2 | 1.60278189 |
29 | INSRR | 1.59594714 |
30 | MAP2K4 | 1.48478685 |
31 | DAPK2 | 1.48429869 |
32 | TNK2 | 1.42561818 |
33 | PDGFRA | 1.42417061 |
34 | MAP3K11 | 1.40949938 |
35 | FGFR4 | 1.30614431 |
36 | PTK6 | 1.28448681 |
37 | CAMK1D | 1.27768299 |
38 | PAK3 | 1.27257763 |
39 | FES | 1.26963937 |
40 | MAP3K14 | 1.25318039 |
41 | STK38 | 1.24215831 |
42 | MAP3K7 | 1.23244038 |
43 | NTRK1 | 1.22024363 |
44 | FRK | 1.21847826 |
45 | PAK6 | 1.19791753 |
46 | MAP3K4 | 1.19714031 |
47 | LATS2 | 1.18653896 |
48 | RET | 1.16436715 |
49 | TYRO3 | 1.16423705 |
50 | PRKCH | 1.16092666 |
51 | WNK4 | 1.13845051 |
52 | BTK | 1.13658988 |
53 | SIK2 | 1.11966571 |
54 | HCK | 1.11211699 |
55 | JAK3 | 1.11120416 |
56 | DYRK1B | 1.10487709 |
57 | TAOK2 | 1.09614850 |
58 | SMG1 | 1.09524306 |
59 | PHKG2 | 1.07994260 |
60 | PHKG1 | 1.07994260 |
61 | TBK1 | 1.06590443 |
62 | IRAK2 | 1.05816835 |
63 | SIK3 | 1.05659403 |
64 | CAMKK1 | 1.04470015 |
65 | PIK3CG | 1.03279734 |
66 | IRAK3 | 1.01895691 |
67 | IKBKE | 1.01616226 |
68 | TTN | 0.99614900 |
69 | GRK6 | 0.98399361 |
70 | FGFR2 | 0.97721249 |
71 | PDK2 | 0.95931047 |
72 | SYK | 0.95491931 |
73 | PTK2B | 0.92788980 |
74 | CDC42BPA | 0.90727676 |
75 | CAMKK2 | 0.89837905 |
76 | MARK3 | 0.88996026 |
77 | PDPK1 | 0.88172273 |
78 | MST1R | 0.87712966 |
79 | TAOK1 | 0.87652491 |
80 | PRKAA1 | 0.86535578 |
81 | MTOR | 0.84307517 |
82 | PDK1 | 0.84001724 |
83 | ALK | 0.83995368 |
84 | STK11 | 0.83095911 |
85 | IRAK1 | 0.82889400 |
86 | EPHB1 | 0.82638482 |
87 | NTRK3 | 0.81030660 |
88 | EEF2K | 0.80324716 |
89 | PDGFRB | 0.79655099 |
90 | KSR1 | 0.79302015 |
91 | PTK2 | 0.78468029 |
92 | BMX | 0.78359739 |
93 | MINK1 | 0.77976679 |
94 | DMPK | 0.77707216 |
95 | SCYL2 | 0.76478407 |
96 | TXK | 0.75981467 |
97 | MET | 0.74037125 |
98 | CSF1R | 0.73881881 |
99 | MARK1 | 0.72827670 |
100 | MAPK7 | 0.72610971 |
101 | MOS | 0.72316647 |
102 | SGK3 | 0.71633259 |
103 | ITK | 0.70705127 |
104 | MAP3K1 | 0.70469518 |
105 | FGR | 0.70345921 |
106 | MARK2 | 0.67957735 |
107 | RPS6KL1 | 0.67866378 |
108 | RPS6KC1 | 0.67866378 |
109 | LMTK2 | 0.67278274 |
110 | TAOK3 | 0.66303251 |
111 | DDR2 | 0.65090316 |
112 | JAK2 | 0.64897006 |
113 | GSK3A | 0.64821097 |
114 | STK10 | 0.64583297 |
115 | SGK2 | 0.64432960 |
116 | EPHA4 | 0.64221769 |
117 | LCK | 0.64094565 |
118 | LYN | 0.63284571 |
119 | ERBB2 | 0.63116748 |
120 | WNK1 | 0.62792320 |
121 | JAK1 | 0.62333853 |
122 | NEK9 | 0.62188941 |
123 | PRKD2 | 0.61670132 |
124 | RPS6KA2 | 0.61619095 |
125 | PRKAA2 | 0.61390229 |
126 | PRKCZ | 0.61376072 |
127 | TGFBR2 | 0.61260054 |
128 | MAP2K1 | 0.60185049 |
129 | CDK6 | 0.59585026 |
130 | PRKD1 | 0.59108038 |
131 | FGFR3 | 0.58795431 |
132 | ARAF | 0.58502131 |
133 | CAMK4 | 0.57338284 |
134 | CDK5 | 0.56576351 |
135 | TRPM7 | 0.56529837 |
136 | YES1 | 0.56510717 |
137 | RPS6KA6 | 0.54607626 |
138 | PAK2 | 0.53911840 |
139 | HIPK2 | 0.53148922 |
140 | FER | 0.51926451 |
141 | LRRK2 | 0.51819618 |
142 | UHMK1 | 0.51061809 |
143 | ERBB4 | 0.50446782 |
144 | MAPK12 | 0.50219937 |
145 | MAPK11 | 0.47385225 |
146 | PNCK | 0.46511529 |
147 | STK39 | 0.46111438 |
148 | CDK12 | 0.45208908 |
149 | EPHB2 | 0.43716364 |
150 | TESK1 | 0.43550391 |
151 | MAP3K6 | 0.43114042 |
152 | IKBKB | 0.41901203 |
153 | SGK223 | 0.38423913 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.30006785 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.15124687 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12205586 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71197464 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43755081 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33596951 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26811553 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22067700 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.15775414 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11453787 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05273166 |
12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04091628 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02169975 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96664741 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93261070 |
16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.92367032 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91306250 |
18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.87802207 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81315862 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81218204 |
21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.81116197 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.79846497 |
23 | Bile secretion_Homo sapiens_hsa04976 | 1.77320451 |
24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.76373597 |
25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76116234 |
26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71679318 |
27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68252947 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.66157974 |
29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.65811642 |
30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.59487636 |
31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58014805 |
32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53616651 |
33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50537901 |
34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41217823 |
35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39633683 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39566400 |
37 | Measles_Homo sapiens_hsa05162 | 1.36773493 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36311021 |
39 | Malaria_Homo sapiens_hsa05144 | 1.35403447 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35284384 |
41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.35144508 |
42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29663135 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29576751 |
44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28627509 |
45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27755437 |
46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26966296 |
47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.25933273 |
48 | Lysine degradation_Homo sapiens_hsa00310 | 1.25787728 |
49 | Influenza A_Homo sapiens_hsa05164 | 1.25531096 |
50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24653549 |
51 | Allograft rejection_Homo sapiens_hsa05330 | 1.23492634 |
52 | Peroxisome_Homo sapiens_hsa04146 | 1.21564593 |
53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18804968 |
54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18721607 |
55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18709877 |
56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18599761 |
57 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17947924 |
58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17309329 |
59 | Hepatitis B_Homo sapiens_hsa05161 | 1.15845654 |
60 | Hepatitis C_Homo sapiens_hsa05160 | 1.15265275 |
61 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14764228 |
62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13942773 |
63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13754850 |
64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13371038 |
65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13135599 |
66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10937102 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.09472294 |
68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09056646 |
69 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.08768546 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07456298 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.05949686 |
72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05038923 |
73 | ABC transporters_Homo sapiens_hsa02010 | 1.04536221 |
74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03217909 |
75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01301903 |
76 | Platelet activation_Homo sapiens_hsa04611 | 1.00839276 |
77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00094744 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99369737 |
79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98484327 |
80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97464764 |
81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96885417 |
82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94731671 |
83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91971074 |
84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89988451 |
85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89794711 |
86 | Insulin resistance_Homo sapiens_hsa04931 | 0.89092827 |
87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89036086 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88620332 |
89 | Legionellosis_Homo sapiens_hsa05134 | 0.88439472 |
90 | Phagosome_Homo sapiens_hsa04145 | 0.88414623 |
91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86929542 |
92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86835147 |
93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84140501 |
94 | Apoptosis_Homo sapiens_hsa04210 | 0.83957333 |
95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.82866735 |
96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81354720 |
97 | Amoebiasis_Homo sapiens_hsa05146 | 0.80721785 |
98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80642502 |
99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79159470 |
100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78819397 |
101 | Endocytosis_Homo sapiens_hsa04144 | 0.78422482 |
102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78172001 |
103 | Prostate cancer_Homo sapiens_hsa05215 | 0.77790353 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77260153 |
105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77069145 |
106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76767294 |
107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75886206 |
108 | Pertussis_Homo sapiens_hsa05133 | 0.75384384 |
109 | Lysosome_Homo sapiens_hsa04142 | 0.74755304 |
110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74540712 |
111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74396286 |
112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73961070 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73810151 |
114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72999250 |
115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71723441 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71419253 |
117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70831479 |
118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70725569 |
119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68898391 |
120 | Salmonella infection_Homo sapiens_hsa05132 | 0.67888368 |
121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67777597 |
122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67218581 |
123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65937204 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65813731 |
125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65133756 |
126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65008673 |
127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64987041 |
128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64865412 |
129 | Insulin secretion_Homo sapiens_hsa04911 | 0.64445335 |
130 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63044325 |
131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62890472 |
132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62408234 |
133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61416807 |
134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61011932 |
135 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60708694 |
136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59772378 |
137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59682618 |
138 | Shigellosis_Homo sapiens_hsa05131 | 0.56152321 |
139 | Bladder cancer_Homo sapiens_hsa05219 | 0.56108836 |
140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55893533 |
141 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55687241 |
142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55333988 |
143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54872212 |
144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54324510 |
145 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52040823 |
146 | Focal adhesion_Homo sapiens_hsa04510 | 0.51908707 |
147 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51903975 |
148 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51859257 |
149 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51539382 |
150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51236393 |
151 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50731860 |
152 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49600324 |
153 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48962085 |
154 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48780400 |
155 | Prion diseases_Homo sapiens_hsa05020 | 0.47687954 |
156 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47531571 |
157 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46529457 |
158 | Renin secretion_Homo sapiens_hsa04924 | 0.45746005 |
159 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44709975 |
160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44509679 |
161 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.44161510 |
162 | Glioma_Homo sapiens_hsa05214 | 0.42639347 |
163 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41554478 |
164 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40888334 |
165 | Salivary secretion_Homo sapiens_hsa04970 | 0.39444315 |
166 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38939860 |
167 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38438593 |
168 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38180980 |
169 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35831738 |
170 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34457009 |
171 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32473337 |
172 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30204968 |
173 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29625100 |
174 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.29243660 |
175 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28276385 |
176 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27904893 |
177 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27382961 |
178 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26382211 |
179 | Gap junction_Homo sapiens_hsa04540 | 0.26316293 |